Unsere Publikationen

Driving time-based identification of gaps in specialised care coverage: An example of neuroinflammatory diseases in Germany

Link
https://doi.org/10.1177/20552076231152989
Tags
Multiple Sklerose
Jahr
2023
Autoren
Masanneck L, Räuber S, Schroeter CB, Lehnerer S, Ziemssen T, et al.
Verlag
DIGITAL HEALTH. 2023;9.
Zum Eintrag

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

Link
https://doi.org/10.1073/pnas.2207291120
Tags
Multiple SkleroseMS BehandlungNeuroimmunologie
Jahr
2023
Autoren
Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson KR, Kakara M, Zuroff L, Bennett JL, von Büdingen HC, Carruthers R, Edwards KR, Fallis R, Giacomini PS, Greenberg BM, Hafler DA, Ionete C, Kaunzner UW, Lock CB, Longbrake EE, Pardo G, Piehl F, Weber MS, Ziemssen T, Jacobs D, Gelfand JM, Cross AH, Cameron B, Musch B, Winger RC, Jia X, Harp CT, Herman A, Bar-Or A.
Verlag
Proc Natl Acad Sci U S A. 2023 Jan 17;120(3):e2207291120.
Zum Eintrag

Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies

Link
https://doi.org/10.1212/NXI.0000000000200064
Tags
Multiple Sklerose
Jahr
2023
Autoren
Ziemssen T, Bhan V, Chataway J, Chitnis T, Campbell Cree BA, Havrdova EK, et al.
Verlag
Neurol Neuroimmunol Neuroinflamm 2023;10(1).
Zum Eintrag

Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab

Link
https://doi.org/10.3390/vaccines10122167
Tags
Multiple SkleroseMS Behandlung
Jahr
2022
Autoren
Ziemssen T, Groth M, Ettle B, Bopp T.
Verlag
Vaccines (Basel). 2022 Dec 16;10(12):2167.
Zum Eintrag

Efficacy of prolonged-release fampridine versus placebo on walking ability, dynamic and static balance, physical impact of multiple sclerosis, and quality of life: an integrated analysis of MOBILE and ENHANCE

Link
https://doi.org/10.1177/17562864221090398
Tags
Multiple SkleroseMS BehandlungMobilität
Jahr
2022
Autoren
Hupperts R, Gasperini C, Lycke J, Ziemssen T, Feys P, Xiao S, Acosta C, Koster T, Hobart J.
Verlag
Ther Adv Neurol Disord. 2022 May 18;15:17562864221090398.
Zum Eintrag

Exploring in vivo lesion myelination dynamics: Longitudinal Myelin Water Imaging in early Multiple Sclerosis

Link
https://doi.org/10.1016/j.nicl.2022.103192
Tags
Multiple Sklerose
Jahr
2022
Autoren
Kitzler HH, Wahl H, Kuntke P, Deoni SCL, Ziemssen T, Linn J, Köhler C.
Verlag
Neuroimage Clin. 2022;36:103192.
Zum Eintrag

S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review

Link
https://doi.org/10.1177/17562864221133163
Tags
Multiple SkleroseMS BehandlungAutonomes Nervensystem & NeuroendokrinologieHerzratenvariabilität
Jahr
2022
Autoren
Constantinescu V, Haase R, Akgün K, Ziemssen T.
Verlag
Ther Adv Neurol Disord. 2022 Nov 22;15:17562864221133163.
Zum Eintrag

OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany

Link
https://doi.org/10.3389/fneur.2022.913616
Tags
Multiple SkleroseMS BehandlungManagement & Science
Jahr
2022
Autoren
Ziemssen T, Richter S, Mäurer M, Buttmann M, Kreusel B, Poehler AM, Lampl M, Linker RA.
Verlag
Front Neurol. 2022 Jun 27;13:913616.
Zum Eintrag
8 9 10 11 12

Publikationen durchsuchen

Publikationen filtern

Filter
Tags
Multiple Sklerose
MS Behandlung
Mobilität
Autonomes Nervensystem & Neuroendokrinologie
Neuroimmunologie
Herzratenvariabilität
Baroreflexsensitivität
Management & Science
eHealth
Gesundheitsökonomie
Andere
Zeige alleVerstecke
Jahr
-